-
Recent Posts
- Sudden EV Power Loss – Toyota BZ, Lexus RZ, Subaru Solterra Recalled
- Milestones – 15 Million Honda Accords Sold in U.S.
- UAW to “Practice Pickett” Tomorrow at Woodward MPC
- June 2026 U.S. Auto Sales Forecast Up 3.6%
- BMW Expands Factory Use of Humanoid Robots
- “Disasters” – UAW on NAFTA, U.S.-Mexico-Canada Agreements
- Connectivity Snags Haunt Improvements in New-Vehicle Quality
- Trumped! – 2026 Vehicles Sales Forecasts All Down
- Annals of Marketing – Chevrolet Heartbeat of America Revived
- Milestones – Nissan Canton Builds 1 Millionth Frontier Truck
- Porsche AG Board Drastically Cuts 2025 Annual Dividend ~50%
- Ford Recalls Expand – Six More Covering ~172,000 Vehicles
- AAA – Independence Weekend Travel Forecast Flat
- IndyCar – Lundgaard Last-to-First Win at Road America!
- Carry Over Pricing Planned on the 2027 Subara Solterra
Recent Comments
- Magna International on Magna International Posts Q1 2026 EPS Loss of $0.04
- Council on Foreign Relations on Iran and Strait of Hormuz on AAA – Pump Gasoline Prices Still Soaring
- Autocrat on Stellantis Subordinated Perpetual Hybrid Bonds on Stellantis Posts Full Year 2025 Loss of €22.3B
- Michigan Governor Whitmer on Pew – Confidence in Trump Dips, Fewer Support His Policies
- Porsche Motorsport Daytona Victory on Daytona 24 Hours – Old and New Stars Getting Ready to Run
Archives
Meta

Covid – Commerce NIST Grant of $153 million to National Institute for Innovation in Manufacturing Biopharmaceuticals
NIIMBL* will work to increase the shelf life and reduce the amount of refrigeration required for messenger RNA vaccines, boost capabilities for rapid production of antigens used in testing and screening for new variants and develop novel technologies for detecting counterfeit vaccines, among other things. Continue reading →